Prognostic value of the Duke Activity Status Index (DASI) in patients undergoing colorectal surgery

2021 ◽  
Author(s):  
Charbel El-Kefraoui ◽  
Fateme Rajabiyazdi ◽  
Nicolò Pecorelli ◽  
Franco Carli ◽  
Lawrence Lee ◽  
...  
Keyword(s):  
Colorectal Surgery ◽  
Prognostic Value ◽  
Duke Activity Status Index ◽  
Status Index

scholarly journals Prognostic Value of Estimating Functional Capacity With the Use of the Duke Activity Status Index in Stable Patients With Chronic Heart Failure

2015 ◽  
Vol 21 (1) ◽  
pp. 44-50 ◽  
Author(s):  
Justin L. Grodin ◽  
Muhammad Hammadah ◽  
Yiying Fan ◽  
Stanley L. Hazen ◽  
W.H. Wilson Tang
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Functional Capacity ◽  
Prognostic Value ◽  
Duke Activity Status Index ◽  
Status Index

scholarly journals Duke Activity Status Index for Cardiovascular Diseases: Validation of the Portuguese Translation

2014 ◽  
Author(s):  
Mariana A. Coutinho-Myrrha ◽  
Rosângela C. Dias ◽  
Aline A. Fernandes ◽  
Christiano G. Araújo ◽  
Mark A. Hlatky ◽  
...  
Keyword(s):  
Cardiovascular Diseases ◽  
Duke Activity Status Index ◽  
Status Index

Relation of clinical and angiographic factors to functional capacity as measured by the Duke Activity Status Index

1991 ◽  
Vol 68 (9) ◽  
pp. 973-975 ◽  
Author(s):  
Charlotte L. Nelson ◽  
James E. Herndon ◽  
Daniel B. Mark ◽  
David B. Pryor ◽  
Robert M. Califf ◽  
...  
Keyword(s):  
Functional Capacity ◽  
Duke Activity Status Index ◽  
Status Index

scholarly journals Microvascular Assessment of Ranolazine in Non-Obstructive Atherosclerosis

2020 ◽  
Vol 13 (12) ◽  
Author(s):  
Jin-Sin Koh ◽  
Olivia Y. Hung ◽  
Parham Eshtehardi ◽  
Arnav Kumar ◽  
Rani Rabah ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Fractional Flow ◽  
Flow Reserve ◽  
Nonobstructive Coronary Artery Disease ◽  
Angina Frequency ◽  
Duke Activity Status Index ◽  
Artery Disease ◽  
Status Index ◽  
Frequency Score

Background: Microvascular dysfunction is known to play a key role in patients with angina and nonobstructive coronary artery disease. We investigated the impact of ranolazine among patients with angina and nonobstructive coronary artery disease. Methods: In this randomized, double-blinded, placebo-controlled pilot trial, 26 patients with angina once weekly or more, abnormal stress test, and nonobstructive coronary artery disease (<50% stenosis by angiography and fractional flow reserve >0.80) were randomized 1:1 to ranolazine or placebo for 12 weeks. Primary end point was ΔSeattle Angina Questionnaire (SAQ) angina frequency score. Baseline and 3 months follow-up SAQ, Duke Activity Status Index scores along with invasive fractional flow reserve, coronary flow reserve (CFR), hyperemic myocardial resistance, and cardiopulmonary exercise testing measurements were performed. Results: No significant differences in ΔSAQ angina frequency scores ( P =0.53) or Duke Activity Status Index ( P =0.76) were observed between ranolazine versus placebo, although patients on ranolazine had lesser improvement in SAQ physical limitation scores ( P =0.02) compared with placebo at 3 months. There were no significant differences in ΔCFR or Δhyperemic myocardial resistance between ranolazine and placebo groups. Patients treated with ranolazine, compared with placebo, had no significant improvement in maximum rate of oxygen consumption measured during incremental exercise (VO 2 max) and peak metabolic equivalents of task. Interestingly, in the ranolazine group, patients with baseline CFR<2.0 demonstrated greater gain in CFR compared with those with baseline CFR≥2.0 ( P =0.02). Conclusions: Ranolazine did not demonstrate improvement in SAQ angina frequency score, invasive microvascular function, or peak metabolic equivalent compared with placebo at 3 months. Registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT02147067.

Middle Ear Obliteration with Blind-Sac Closure of the External Auditory Canal for Spontaneous CSF Otorrhea

2016 ◽  
Vol 156 (3) ◽  
pp. 534-542 ◽  
Author(s):  
Shawn M. Stevens ◽  
Ryan Crane ◽  
Myles L. Pensak ◽  
Ravi N. Samy
Keyword(s):  
Body Mass Index ◽  
Cerebrospinal Fluid ◽  
Body Mass ◽  
Middle Ear ◽  
External Auditory Canal ◽  
Cardiac Risk ◽  
Mastoid Obliteration ◽  
Duke Activity Status Index ◽  
Blind Sac Closure ◽  
Status Index

Outcome Objectives To (1) identify unique features of patients who underwent middle ear/mastoid obliteration with blind-sac closure of the external auditory canal for spontaneous cerebrospinal fluid (CSF) otorrhea and (2) explore outcomes. Study Design Case series with chart review. Setting Tertiary care center. Subjects and Methods Adults treated for spontaneous cerebrospinal fluid otorrhea from 2007 through 2015 were reviewed and stratified into 2 groups based on the surgery performed: (1) 11 patients underwent middle ear/mastoid obliteration with blind-sac closure of the external auditory canal and (2) 26 patients underwent other procedures. Demographics, body mass index, revised cardiac risk index, Duke Activity Status Index scores, and anticoagulation use were documented. Audiologic data were gathered from pre- and postoperative visits. The primary outcome measure was leak recurrence. Complications were tabulated. Results Poor preoperative hearing was a relative indication for obliteration. Obliteration patients had higher body mass index (43.2 vs 34.9 kg/m2; P < .05), incidence of super-morbid obesity (45% vs 7.6%; P = .015), anticoagulation usage (36% vs 0%; P = .004), cardiac risk scores (1.2 vs 0.1 dB; P < .0004), and Duke Activity Status Index scores. There was 1 leak recurrence (9%). Major and minor complication rates were 9% and 36%, respectively. Mean follow-up was 30.8 ± 8.6 months. Conclusion Middle ear and mastoid obliteration with blind-sac closure of the external auditory canal is effective for treating spontaneous CSF otorrhea. The small cohort reviewed did not experience any major perioperative morbidity. The technique may be best suited for patients with poor hearing, the infirm, and those in whom craniotomy is contraindicated.

Psychometric testing of the Duke Activity Status Index in patients with heart failure

2014 ◽  
Vol 14 (3) ◽  
pp. 214-221 ◽  
Author(s):  
Xiuzhen Fan ◽  
Kyoung Suk Lee ◽  
Susan K Frazier ◽  
Terry A Lennie ◽  
Debra K Moser
Keyword(s):  
Heart Failure ◽  
Psychometric Testing ◽  
Patients With Heart Failure ◽  
Duke Activity Status Index ◽  
Status Index

scholarly journals Clinical Application Of Duke Activity Status Index To Select An Appropriate Cardiovascular Stress Test Protocol

2020 ◽  
Vol 52 (7S) ◽  
pp. 635-635
Author(s):  
Mary Ann Reynolds ◽  
Rachel Myers ◽  
Josh West ◽  
Katey Sweat ◽  
Virginia McGhee ◽  
...  
Keyword(s):  
Clinical Application ◽  
Stress Test ◽  
Test Protocol ◽  
Cardiovascular Stress ◽  
Duke Activity Status Index ◽  
Status Index
Sign in / Sign up

Export Citation Format

Share Document